A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns.

Authors

Angela L F Gibson, University of Wisconsin School of Medicine and Public Health
James H Holmes, Wake Forest University School of Medicine
Jeffrey W Shupp, Medstar Washington Hospital Center, Washington, DC
David Smith, University of South Florida
Victor Joe, University of California at Irvine
Joshua Carson, University of Florida
Jeffrey Litt, University of Missouri Health Care
Steven Kahn, Medical University of South Carolina
Tracee Short, Baton Rouge General Medical Center
Leopoldo Cancio, United States Army Institute of Surgical Research , Fort Sam Houston, T
Julie Rizzo, United States Army Institute of Surgical Research , Fort Sam Houston, T
Jeffrey E Carter, LSU Health Sciences Center - New OrleansFollow
Kevin Foster, The Arizona Burn Center at MIHS , Phoenix, AZ
B Lynn Allen-Hoffmann, University of Wisconsin School of Medicine and Public Health

Document Type

Conference Proceeding

Publication Date

4-1-2021

Publication Title

Journal of Burn Care & Research

Abstract

American Burn Association 53rd Annual Meeting

First Page

S25

Last Page

S26

Volume

42

Issue

Supplement 1

Comments

Abstract Number: 31

Recommended Citation

Gibson, Angela L F; Holmes, James H; Shupp, Jeffrey W; Smith, David; Joe, Victor; Carson, Joshua; Litt, Jeffrey; Kahn, Steven; Short, Tracee; Cancio, Leopoldo; Rizzo, Julie; Carter, Jeffrey E; Foster, Kevin; and Allen-Hoffmann, B Lynn, "A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns." (2021). School of Medicine Faculty Publications. 898.
https://digitalscholar.lsuhsc.edu/som_facpubs/898